Literature DB >> 31227790

Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.

Ah Jin Lee1, Soo Hyun Nam2, Jin-Mo Park3, Sumaira Kanwal4, Yu Jin Choi1, Hyun Jung Lee1, Kyung Suk Lee5, Ji Eun Lee6,7, Jin-Sung Park8, Byung-Ok Choi9,10, Ki Wha Chung11.   

Abstract

Charcot-Marie-Tooth disease type 4C (CMT4C) is an autosomal recessive neuropathy caused by SH3TC2 mutations, characterized by spine deformities and cranial nerve involvement. This study identified four CMT4C families with compound heterozygous SH3TC2 mutations from 504 Korean demyelinating or intermediate CMT patients. The frequency of the CMT4C was calculated as 0.79% in demyelinating and intermediate patients (n = 504), but it was calculated as 2.02% in patients without PMP22 duplication (n = 198). The CMT4C frequency was similar to patients in Japan, but it was relatively low compared to those patients in other populations. The symptom was less severe and slowly progressed compared to the other AR-CMT. A patient harboring an intermediate neuropathy showed cranial nerve involvement but did not have scoliosis. This study will be helpful in making molecular diagnoses of demyelinating or intermediate CMT due to SH3TC2 mutations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31227790     DOI: 10.1038/s10038-019-0636-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

1.  A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes.

Authors:  R Gooding; J Colomer; R King; D Angelicheva; L Marns; Y Parman; D Chandler; J Bertranpetit; L Kalaydjieva
Journal:  J Med Genet       Date:  2005-12       Impact factor: 6.318

2.  Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).

Authors:  Giuseppe Piscosquito; Paola Saveri; Stefania Magri; Claudia Ciano; Claudia Gandioli; Michela Morbin; Daniela D Bella; Isabella Moroni; Franco Taroni; Davide Pareyson
Journal:  J Peripher Nerv Syst       Date:  2016-09       Impact factor: 3.494

3.  Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.

Authors:  S Rudnik-Schöneborn; D Tölle; J Senderek; K Eggermann; M Elbracht; U Kornak; M von der Hagen; J Kirschner; B Leube; W Müller-Felber; U Schara; K von Au; D Wieczorek; C Bußmann; K Zerres
Journal:  Clin Genet       Date:  2015-04-29       Impact factor: 4.438

4.  Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.

Authors:  Jun-Hui Yuan; Akihiro Hashiguchi; Yuji Okamoto; Akiko Yoshimura; Masahiro Ando; Kazutaka Shiomi; Kayoko Saito; Makoto Takahashi; Keiko Ichinose; Takuma Ohmichi; Kazushi Ichikawa; Adachi Tadashi; Hiroshi Takigawa; Hidehiro Shibayama; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

5.  High frequency of SH3TC2 mutations in Czech HMSN I patients.

Authors:  P Laššuthová; R Mazanec; P Vondráček; D Sišková; J Haberlová; J Sabová; P Seeman
Journal:  Clin Genet       Date:  2011-03-01       Impact factor: 4.438

6.  Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy.

Authors:  Jan Senderek; Carsten Bergmann; Claudia Stendel; Jutta Kirfel; Nathalie Verpoorten; Peter De Jonghe; Vincent Timmerman; Roman Chrast; Mark H G Verheijen; Greg Lemke; Esra Battaloglu; Yesim Parman; Sevim Erdem; Ersin Tan; Haluk Topaloglu; Andreas Hahn; Wolfgang Müller-Felber; Nicolò Rizzuto; Gian Maria Fabrizi; Manfred Stuhrmann; Sabine Rudnik-Schöneborn; Stephan Züchner; J Michael Schröder; Eckhard Buchheim; Volker Straub; Jörg Klepper; Kathrin Huehne; Bernd Rautenstrauss; Reinhard Büttner; Eva Nelis; Klaus Zerres
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

7.  Wide phenotypic spectrum in axonal Charcot-Marie-Tooth neuropathy type 2 patients with KIF5A mutations.

Authors:  Da Eun Nam; Da Hye Yoo; Sun Seong Choi; Byung-Ok Choi; Ki Wha Chung
Journal:  Genes Genomics       Date:  2017-10-10       Impact factor: 1.839

8.  Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C.

Authors:  Rhys C Roberts; Andrew A Peden; Folma Buss; Nicholas A Bright; Morwena Latouche; Mary M Reilly; John Kendrick-Jones; J Paul Luzio
Journal:  Hum Mol Genet       Date:  2009-12-22       Impact factor: 6.150

9.  The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy.

Authors:  Christina DiVincenzo; Christopher D Elzinga; Adam C Medeiros; Izabela Karbassi; Jeremiah R Jones; Matthew C Evans; Corey D Braastad; Crystal M Bishop; Malgorzata Jaremko; Zhenyuan Wang; Khalida Liaquat; Carol A Hoffman; Michelle D York; Sat D Batish; James R Lupski; Joseph J Higgins
Journal:  Mol Genet Genomic Med       Date:  2014-08-21       Impact factor: 2.183

10.  Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing.

Authors:  Soo Hyun Nam; Young Bin Hong; Young Se Hyun; Da Eun Nam; Geon Kwak; Sun Hee Hwang; Byung-Ok Choi; Ki Wha Chung
Journal:  Mol Cells       Date:  2016-03-30       Impact factor: 5.034

View more
  3 in total

1.  Characteristics of Clinical and Electrophysiological Pattern in a Large Cohort of Chinese Patients With Charcot-Marie-Tooth 4C.

Authors:  Xiaohui Duan; Yan Ma; Dongsheng Fan; Xiaoxuan Liu
Journal:  Front Neurol       Date:  2021-02-12       Impact factor: 4.003

2.  Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients.

Authors:  Bo Sun; Zheng-Qing He; Yan-Ran Li; Jiong-Ming Bai; Hao-Ran Wang; Hong-Fen Wang; Fang Cui; Fei Yang; Xu-Sheng Huang
Journal:  Acta Neurol Belg       Date:  2021-02-15       Impact factor: 2.471

3.  Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway.

Authors:  Chengzhi Huang; Hui Yi; Yue Zhou; Qing Zhang; Xueqing Yao
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.